Community Perspective on HIV Research at the End of Life

Dr Sara Gianella Weibel talks with Jeff Taylor, community activist and long-term HIV survivor, about a new end-of-life model to study HIV persistence.

Study to Examine Effects of PrEP in Transgender Population

Dr Sara Gianella talks with Dr Sheldon Morris, from the University of California San Diego AntiViral Research Center about an upcoming PrEP study in transgender ...

HIV Transmission Through Breastfeeding

Mother-to-child HIV transmission rates are low in the presence of antiretroviral therapy but increase once ART stops at 6 months postpartum.

A Transgender Woman’s Perspective on HIV Prevention and Care

Dr Sara Gianella talks with Brooke Sullivan, a transgender woman and HIV activist, about ways to improve transgender individuals' involvement in HIV research.

Cardiovascular Disease in HIV

Persons living with HIV infection have a higher risk for cardiovascular disease; use of some antiretroviral agents can exacerbate this risk.

Latest News

Addition of IL-2 to ART in HIV Offers No Significant Benefit

Addition of IL-2 to ART in HIV Offers No Significant Benefit

Interleukin-2 (IL-2) to antiretroviral therapy (ART) does not confer any significant benefit in mortality in patients with HIV.

Pharmacokinetic Assessment Shows Value in HIV

Pharmacokinetic Assessment Shows Value in HIV

Pharmacokinetic assessment is a major component in choosing route of admission with antiretroviral agents for HIV infection.

Early ART Initiation May Increase Bone Loss in Patients With HIV

Early ART Initiation May Increase Bone Loss in Patients With HIV

Early antiretroviral therapy initiation may increase the rate of bone loss in HIV patients.

Amphotericin B Better Than Itraconazole in HIV-Linked Talaromycosis

Amphotericin B Better Than Itraconazole in HIV-Linked Talaromycosis

Treatment with antifungal drug amphotericin B is superior to itraconazole for HIV-associated talaromycosis.

Does ART Increase Risk of Diabetes in HIV-infected Patients?

Does ART Increase Risk of Diabetes in HIV-infected Patients?

Antiretroviral therapy may be the most consistent determinant of diabetes in patients with HIV.

HIV Testing Insufficient in Young MSM

HIV Testing Insufficient in Young MSM

A new study finds that not enough young MSM receive HIV testing despite accounting for most new diagnosis.

Financial Incentives Offer Promise in Improving HIV Viral Suppression

Financial Incentives Offer Promise in Improving HIV Viral Suppression

Financial incentives increase viral suppression in HIV-positive patients.

Reduced Corneal Nerve Fiber Density in HIV-associated Sensory Neuropathy

Reduced Corneal Nerve Fiber Density in HIV-associated Sensory Neuropathy

Patients with HIV and HIV-associated sensory neuropathy (HIV-SN) have reduced corneal nerve fiber density.

Vaginal Microbiome May Render HIV Tenofovir Microbicide Less Effective

Vaginal Microbiome May Render HIV Tenofovir Microbicide Less Effective

Tenofovir gel reduced the incidence of HIV infection by 61% in women with Lactobacillus-dominant vaginal flora but only 18% in women with non-Lactobacillus bacteria, according to a new study.

Advanced Disease, Mental Comorbidity Affect QoL Among Military HIV Patients

Advanced Disease, Mental Comorbidity Affect QoL Among Military HIV Patients

Researchers determined the factors affecting health-related quality of life in military HIV patients.

Feature Article

Last Gift Study: A Participant's Perspective on End-of-Life HIV Research

Last Gift Study: A Participant's Perspective on End-of-Life HIV Research

Dr Sara Gianella Weibel talks with Anthony B, a patient with HIV and end-stage amyotrophic lateral sclerosis and the first participant enrolled in the "Last Gift" end-of-life study, about his experience as part of this new end-of-life model to study HIV persistence.

Last Gift Study: End-of-Life HIV Research

Last Gift Study: End-of-Life HIV Research

Dr Sara Gianella Weibel talks with Dr Davey Smith, head of the Division of Infectious Disease at the University of California, San Diego, about a proposed new model to study HIV persistence, called the Last Gift study.

Should the FDA Lift the Ban on Blood Donations From MSM?

Should the FDA Lift the Ban on Blood Donations From MSM?

Critics of the FDA's current restriction on blood donation from MSM argue that it is unnecessary and discriminatory, and propose a policy based on individual risk rather than sexual orientation.

HIV Research in Women: Expert Q&A

HIV Research in Women: Expert Q&A

Drs Gianella and Karris discuss the many factors that play a role in the underrepresentation of women in HIV research.

Confronting Coronary Heart Disease in HIV/AIDS

Confronting Coronary Heart Disease in HIV/AIDS

A review of coronary heart disease in patients with HIV.

HIV Care Continuum: Improving Future Outcomes

HIV Care Continuum: Improving Future Outcomes

While 86% of all persons living with HIV in the US know that they are HIV-infected, only an estimated 35% actually achieve viral suppression.

Efforts to Boost HIV Testing Rates Working, But Work Remains

Efforts to Boost HIV Testing Rates Working, But Work Remains

Ramped up efforts to encourage more men who have sex with men to get tested for HIV have made an impact, but rates are still lower than needed.

IDSA Guidelines Urge 'Prompt Coordinated Treatment' for HIV and TB

IDSA Guidelines Urge 'Prompt Coordinated Treatment' for HIV and TB

The guidelines note that TB treatment should begin as soon as the patient is suspected of having active TB disease, even before test results confirm the diagnosis.

Traveling the HIV Spectrum With an HIV/AIDS Specialist in the Developed and Developing Worlds

Traveling the HIV Spectrum With an HIV/AIDS Specialist in the Developed and Developing Worlds

Gary Blick, MD, shares his 30+ years of experience in treating HIV.

Social Media Could Help Increase HIV Testing Rates

Social Media Could Help Increase HIV Testing Rates

Following the year-long study period, the intervention group had a testing rate of 63.7% and the comparison group had 42%.

Slideshows

SIGN UP FOR FREE E-NEWSLETTERS